Drug recall · Higher risk

Cetirizine Hydrochloride Tablets USP 5 mg — Recall Lot Numbers & Code Check

Brand: Rising Pharma Company: Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Announced: 2026-07-18
Trending recalls:

Why it was recalled

Potential cross-contamination with ranitidine. Tablets may show red dots or discoloration. For people with hypersensitivity to ranitidine, ingestion could cause serious, life-threatening reactions including anaphylaxis.

Affected codes

GY825029 GY825030 GY825031 GY825032

Recalled lots are packaged in HDPE bottles of 100 tablets, NDC 16571-401-10, expiration date 10/2028, distributed nationwide by Rising Pharma Holdings Inc. All four recalled lots carry the same expiration date (October 2028).

What to do — refund & return steps

  1. Stop taking tablets from a recalled lot.
  2. Contact Rising Pharma Holdings Inc. at 1-844-874-7464 (Mon–Fri, 8 a.m.–5 p.m. EST) or pv@risingpharma.com / qa@risingpharma.com for return and refund instructions.
  3. Talk to your physician or healthcare provider if you have experienced any problems that may be related to taking this product.
  4. Adverse reactions can be reported to FDA MedWatch at www.fda.gov/medwatch/report.htm or 1-800-332-1088.
Official source: U.S. Food and Drug Administration (company announcement, July 18, 2026)
Information on this page verified 2026-07-23. Recall Lot Check is independent and not affiliated with the issuing agency.

Frequently asked questions

Which codes are affected by the Rising Pharma recall?

Recalled lots are packaged in HDPE bottles of 100 tablets, NDC 16571-401-10, expiration date 10/2028, distributed nationwide by Rising Pharma Holdings Inc. All four recalled lots carry the same expiration date (October 2028).

What should I do if my product matches the recall?

Stop taking tablets from a recalled lot. Contact Rising Pharma Holdings Inc. at 1-844-874-7464 (Mon–Fri, 8 a.m.–5 p.m. EST) or pv@risingpharma.com / qa@risingpharma.com for return and refund instructions. Talk to your physician or healthcare provider if you have experienced any problems that may be related to taking this product. Adverse reactions can be reported to FDA MedWatch at www.fda.gov/medwatch/report.htm or 1-800-332-1088.

Where does this recall information come from?

From the official notice published by U.S. Food and Drug Administration (company announcement, July 18, 2026). Recall Lot Check is an independent tool that republishes this public safety information with a link to the original source. Data on this page was verified on 2026-07-23.